Immune Checkpoint Blockade in Lung Cancer

被引：0
|
作者：
Somasundaram, Aswin [1 ]
Socinski, Mark A. [1 ]
Villaruz, Liza C. [1 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Div Hematol Oncol, Pittsburgh, PA 15232 USA
来源：
DISCOVERY MEDICINE | 2016年 / 22卷 / 119期
关键词：
UP-REGULATION; DOUBLE-BLIND; MULTICENTER; EXPRESSION; NIVOLUMAB; SAFETY; LYMPHOCYTES; DOCETAXEL; ANTIBODY; PHASE-2;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Immunotherapy has revolutionized the therapeutic landscape of advanced lung cancer. The adaptive immune system has developed a sophisticated method of tumor growth control, but T-cell activation is regulated by various checkpoints. Blockade of the immune checkpoints with therapies targeting the PD-1 pathway, such as nivolumab and pembrolizumab, has been validated as a therapeutic approach in non-small cell lung cancer. Newer therapies and novel combinations are also being evaluated, and the use of biomarkers in conjunction with these drugs is an area of active investigation. This review summarizes the current evidence for the efficacy and safety of the above approaches in the treatment of lung cancer.
引用
收藏
页码：56 / 66
页数：11
相关论文
共 50 条
  • [21] Re: Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis
    Ikeda, Satoshi
    Kato, Terufumi
    Kenmotsu, Hirotsugu
    Okamoto, Hiroaki
    Ogura, Takashi
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 151 : 249 - 251
  • [22] Bmi1 Resistance Pathway and Immune Checkpoint Blockade in Lung Cancer
    Chaudhary, K. R.
    Halmos, B.
    Cheng, H.
    Cheng, S. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E432 - E433
  • [23] The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System
    Moon, Edmund K.
    Langer, Corey J.
    Albelda, Steven M.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (08) : 1248 - 1260
  • [24] The cutting-edge progress of immune-checkpoint blockade in lung cancer
    Zhou, Fei
    Qiao, Meng
    Zhou, Caicun
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (02) : 279 - 293
  • [25] Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?
    Paglialunga, Luca
    Salih, Zena
    Ricciuti, Biagio
    Califano, Raffaele
    [J]. ESMO OPEN, 2016, 1 (04)
  • [26] A review of immune checkpoint blockade in breast cancer
    Pellegrino, Benedetta
    Tommasi, Chiara
    Cursio, Olga Elisabetta
    Musolino, Antonino
    Migliori, Edoardo
    De Silva, Pushpamali
    Senevirathne, Thilini Hemali
    Schena, Marina
    Scartozzi, Mario
    Farci, Daniele
    Willard-Gallo, Karen
    Solinas, Cinzia
    [J]. SEMINARS IN ONCOLOGY, 2021, 48 (03) : 208 - 225
  • [27] Gastric Cancer in the Era of Immune Checkpoint Blockade
    Figueroa-Protti, Lucia
    Soto-Molinari, Rebeca
    Calderon-Osorno, Melany
    Mora, Javier
    Alpizar-Alpizar, Warner
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [28] Immune Checkpoint Blockade in Breast Cancer Therapy
    Bu, Xia
    Yao, Yihui
    Li, Xiaoyu
    [J]. TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 383 - 402
  • [29] Immune checkpoint blockade therapy in cancer and beyond
    Minato, Nagahiro
    [J]. CYTOKINE, 2017, 100 : 23 - 23
  • [30] Immune Checkpoint Blockade in Metastatic Urothelial Cancer
    Balar, Arjun Vasant
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2109 - +
12345